In this study, we undertook a comprehensive pan-cancer analysis of PDE2A expression, aiming to decipher its differential expression patterns across diverse human cancers and correlate these patterns with clinicopathological features, prognostic outcomes, genetic alterations, immunological functions, and drug sensitivity. The gene discussed is PDE2A; the disease is cancer.